arXiv subjects

Hayley E Jones

Publications and source records attributed to Hayley E Jones.

3 recordsLinked to original sources

arXiv2026

Meta-analysis of networks of diagnostic tests with binary and continuous results

Network meta-analysis of diagnostic test accuracy (NMA-DTA) is a relatively new field, involving combining evidence across studies to evaluate and compare the accuracy of different tests for a given condition. However, the methods proposed to date cannot always capture complex aspects of the data. In fact, many commonly used diagnostic tests are continuous biomarkers, whose accuracy is evaluated at multiple thresholds within a study. Using current NMA-DTA methods we are feasibly able to include in our analysis only a few thresholds per study, discarding this way a big amount of data which could have provided us with useful information. We introduce an approach that can efficiently encompass all available data. This is a hierarchical model that incorporates multinomial likelihoods for studies reporting results across multiple thresholds and a parametric structure for the relationship between the probability of testing positive and threshold within each disease class. This approach enables us to obtain accuracy estimates of tests across the whole range of observed thresholds, while it retains all the useful properties of standard NMA-DTA methods. We explore different variations of this model based on different covariance structures, the inclusion of study-level random effects, and the addition of a further hierarchical structure on the test-level variance components. This framework is applied to data from two systematic reviews, allowing the inclusion of a larger number of tests (compared to alternative approaches) and estimation of sensitivity and specificity at different thresholds with increased precision.

stat.ME↗

arXiv2026

Multi-Parameter Estimation of Prevalence (MPEP): A Bayesian modelling approach to estimate the prevalence of opioid dependence

Estimating the number of the number of people from hidden and/or marginalised populations - such as people dependent on opioids or cocaine - is important to guide policy decisions and provision of harm reduction services. Methods such as capture-recapture are widely used, but rely on assumptions that are often violated and not feasible in specific applications. We describe a Bayesian modelling approach called Multi-Parameter Estimation of Prevalence (MPEP). The MPEP approach leverages routinely collected administrative data, starting from a large baseline cohort of individuals from the population of interest and linked events, to estimate the full size of the target population. When multiple event types are included, the approach enables checking of the consistency of evidence about prevalence from different event types. Additional evidence can be incorporated where inconsistencies are identified. In this article, we summarize the general framework of MPEP, with focus on the most recent version, with improved computational efficiency (implemented in STAN). We also explore several extensions to the model that help us understand the sensitivity of the results to modelling assumptions or identify potential sources of bias. We demonstrate the MPEP approach through a case study estimating the prevalence of opioid dependence in Scotland each year from 2014 to 2022.

stat.ME↗

arXiv2026

Meta-analysis of diagnostic test accuracy with multiple disease stages: combining stage-specific and merged-stage data

For many conditions, it is of clinical importance to know not just the ability of a test to distinguish between those with and without the disease, but also the sensitivity to detect disease at different stages: in particular, the test's ability to detect disease at a stage most amenable to treatment. In a systematic review of test accuracy, pooled stage-specific estimates can be produced using subgroup analysis or meta-regression. However, this requires stage-specific data from each study, which is often not reported. Studies may however report test sensitivity for merged stage categories (e.g. stages I-II) or merged across all stages, together with information on the proportion of patients with disease at each stage. We demonstrate how to incorporate studies reporting merged stage data alongside studies reporting stage-specific data, to allow the inclusion of more studies in the meta-analysis. We consider both meta-analysis of tests with binary results, and meta-analysis of tests with continuous results, where the sensitivity to detect disease of each stage across the whole range of observed thresholds is estimated. The methods are demonstrated using a series of simulated datasets and applied to data from a systematic review of the accuracy of tests used to screen for hepatocellular carcinoma in people with liver cirrhosis. We show that incorporating studies with merged stage data can lead to more precise estimates and, in some cases, corrects biologically implausible results that can arise when the availability of stage-specific data is limited.

stat.ME↗